Curi Bio is a biotechnology company based in Seattle, WA that develops human‑relevant platforms using induced pluripotent stem cell (iPSC)‑derived 2D and 3D tissues. Their products and services focus on mature cardiac, skeletal muscle, and neuromuscular models, as well as biosystem platforms for contractility, voltage, and calcium imaging, complemented by AI/ML‑driven data analytics to accelerate drug discovery, safety, and efficacy testing.